 FORT LAUDERDALE, Fla., Jan. 27, 2021 GLOBE NEWSWIRE -- Motus GI Holdings, Inc., NASDAQ: MOTS Motus GI or the Company, a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that it has signed a warrant exercise agreement with an existing institutional investor that is expected to provide the Company with gross proceeds of up to 11.0 million. 